Castellum, Inc. (CTM) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Castellum, Inc. on April 10, 2025, regarding events occurring in March and April 2025. The Company is an emerging growth company incorporated in Nevada, with its principal executive offices in Vienna, VA. The filing primarily addresses the status of a public offering of units and the subsequent exercise of warrants.
Key Financial Metrics
- Offering Proceeds: The Company raised $4.5 million in gross proceeds from the sale of 4,500,000 units at $1.00 per unit, closed on March 18, 2025.
- Warrant Exercise Proceeds: As of the filing date, investors exercised 1,145,000 warrants, generating $1,236,600 in gross proceeds.
- Outstanding Warrants: 3,355,000 warrants remain unexercised.
- Warrant Terms: Exercise price of $1.08 per share; expiration date of May 16, 2025 (60 days post-issuance).
- Other Metrics: The filing does not provide data on revenue, net profit, operating cash flow, margins, debt levels, or liquidity ratios.
Material Changes
The primary material change is the capital raise activity. Since the closing of the offering on March 18, 2025, approximately 25.4% of the issued warrants (1,145,000 of 4,500,000) have been exercised. This represents a significant near-term cash inflow relative to the initial offering size. The filing notes a typo in the source text regarding the start date of exercises ("March 186"), which is contextually interpreted as March 18, 2025.
Outlook, Risks, and Management Commentary
Management issued a press release on April 10, 2025, to alert holders of the remaining 3,355,000 warrants of the impending expiration deadline on May 16, 2025. The Company has not provided forward-looking guidance on revenue or earnings in this filing. The primary contingency is the potential expiration of the remaining warrants if not exercised by the deadline, which would result in no further proceeds from these specific instruments.
Investor Verification Checklist
- Verify the exact number of warrants exercised and total proceeds received as of the most recent trading day, as the filing only provides data up to April 10, 2025.
- Confirm the dilution impact of the 1,145,000 shares issued upon warrant exercise on the Company's fully diluted share count.
- Review the attached Press Release (Exhibit 99.1) for any additional terms or conditions regarding the warrant exercise process.
- Check subsequent filings for the final count of unexercised warrants expiring on May 16, 2025.